Journal of Cosmetology & Trichology

The skin sensitive syndrome is a widespread condition with an impact on the quality of life of the affected subjects. Cosmetics may be formulated specifically for sensitive skin conditions, alleviating the relative symptoms. The present study aimed at evaluating the efficacy of a natural extract containing polysaccharides from Opuntia ficus-indica (cladodes extract), biophenols from Olea Europaea (olive leaves extract) and flavonoids from Capparis spinosa (caper fruit) on skin discomfort induced by different stressors such as skin redness and skin barrier function alteration by shaving/ epilation; neurogenic mediated by capsaicin; and skin redness induced by UV exposure. Three randomized double-blind, controlled studies were carried out on 20 Caucasian subjects. Product efficacy was measured by means of both instrumental measures (redness and transepidermal water loss, TEWL) and by subjective scoring of the functional signs (itching/stinging and burning sensations) induced by each stressor. The active ingredient showed to decrease: the skin redness and the TEWL after shaving/epilation, the capsaicin-induced skin discomforts and the UV-induced skin redness. Our results demonstrate the ingredient efficacy in decreasing the skin discomforts induced by physical, chemical and environmental agents. The soothing and protective activities besides this cosmetic ingredient might be used in formulations for sensitive skin condition management.

Integrating exploration and scholarly pursuits into the calling of dermatology is essential for advancing the field, improving patient care and fostering professional development. Dermatologists have the opportunity to engage in research, scholarly writing, continuing education and teaching to expand knowledge, refine clinical skills and contribute to the advancement of dermatology. By participating in research, dermatologists can generate new knowledge, improve diagnostic and treatment approaches and provide evidence-based guidance. Scholarly writing allows dermatologists to share expertise, influence clinical practice and gain recognition within the field. Continuing education ensures that dermatologists stay updated with emerging trends and advancements, while academic involvement and teaching activities contribute to the growth of the field and shape the next generation of dermatologists. The integration of exploration and scholarly pursuits in dermatology leads to the advancement of the field, enhanced clinical practice, professional growth and opportunities for networking and collaboration. Embracing academic involvement enriches dermatologists' careers, positively impacts patient outcomes and cultivates a culture of lifelong learning in dermatology.

Dermatology associations play a crucial role in advancing the field of dermatology, providing opportunities for professional development, networking and advocacy. The variety of associations available caters to specific interests and demographics, creating a diverse and supportive community for dermatologists. These associations offer valuable resources, including educational programs, networking platforms, research publications and professional support, enabling dermatologists to enhance their skills, stay updated with advancements and contribute to their respective fields. However, when considering participation in dermatology associations, dermatologists should carefully evaluate the relevance to their professional goals, financial considerations, time commitments and the reputation and credibility of the associations. Active engagement in dermatology associations fosters innovation, collaboration and excellence in the field, benefiting dermatologists and patients alike

Androgenetic Alopecia (AGA) is a progressive hair loss type affecting up to 80% of men and 50% of women. The putative mechanisms in the pathogenesis of AGA include microinflammation, premature cell senescence, oxidative stress, follicle vascular changes and altered sensitivity of hair follicles to androgens. A randomized, double-blind, placebo-controlled trial was carried out on 86 male subjects with AGA from II to III vertex (Hamilton-Norwood). Product efficacy was measured after 3, 6 months of product intake and 1-month post-supplementation. The hair cycle parameters measurement by phototricogram were integrated by the global photography assessment and the self-assessment questionnaire. The results showed an increase of the total hair density and the % of hair in anagen phase with a simultaneous decrease in the % of hair in telogen phase; as consequence the anagen/telogen ratio was improved of about 45.7% and 85.8% at 3 and 6 mo, respectively. The instrumental data were confirmed by the clinical analysis carried out by a board-certified dermatologist and by the self-assessment questionnaire. The obtained improvements were also maintained 1-month post-supplementation. The intake of 250 mg of ActrisaveTM improved the hair life cycle increasing hair growth, density and slowing down hair loss in men with mild-to-moderate androgenetic alopecia.